Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/248265
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner |
Autor: | Barana, Adriana; Amorós, Irene; Caballero, Ricardo; Gómez, Ricardo; Osuna, Lourdes; Lillo, M. Pilar CSIC ORCID; Blázquez, Cristina; Guzmán, Manuel; Delpón, Eva; Tamargo, Juan | Palabras clave: | Anandamide 2-arachidonoylglycerol Kv1.5 Endocannabinoids Fatty acids Arachidonic acid Cardiac potassium channels |
Fecha de publicación: | 1-ene-2010 | Editor: | Elsevier BV | Citación: | Cardiovascular Research 85: 56-67 (2010) | Resumen: | AimsEndocannabinoids are synthesized from lipid precursors at the plasma membranes of virtually all cell types, including cardiac myocytes. Endocannabinoids can modulate neuronal and vascular ion channels through receptor-independent actions; however, their effects on cardiac K+ channels are unknown. This study was undertaken to determine the receptor-independent effects of endocannabinoids such as anandamide (N-arachidonoylethanolamine, AEA), 2-arachidonoylglycerol (2-AG), and endocannabinoid-related compounds such as N-palmitoylethanolamine (PEA), N-oleoylethanolamine (OEA), the endogenous lipid lysophosphatidylinositol (LPI), and the fatty acids from which some of these compounds are endogenously synthesized, on human cardiac Kv1.5 channels, which generate the ultrarapid delayed rectifier current (IKur).Methods and resultshKv1.5 currents (IhKv1.5) were recorded in mouse fibroblasts (Ltk- cells) by using the whole-cell patch-clamp technique. Most of these compounds inhibited IhKv1.5 in a concentration-dependent manner, the potency being determined by the number of C atoms in the fatty acyl chain. Indeed, AEA and 2-AG, which are arachidonic acid (20:4) derivatives, exhibited the highest potency (IC50∼0.9-2.5 M), whereas PEA, a palmitic acid (PA-16:0) derivative, exhibited the lowest potency. The inhibition was independent of cannabinoid receptor engagement and of changes in the order and microviscosity of the membrane. Furthermore, blockade induced by AEA and 2-AG was abolished upon mutation of the R487 residue, which determines the external tetraethylammonium sensitivity and is located in the external entryway of the pore. AEA significantly prolonged the duration of action potentials (APs) recorded in mouse left atria.ConclusionThese results indicate that endocannabinoids block human cardiac Kv1.5 channels by interacting with an extracellular binding site, a mechanism by which these compounds regulate atrial AP shape. | Descripción: | 12 pags, 8 figs. -- Incluye material adicional en la página web del editor | Versión del editor: | http://dx.doi.org/10.1093/cvr/cvp284 | URI: | http://hdl.handle.net/10261/248265 | DOI: | 10.1093/cvr/cvp284 | Identificadores: | doi: 10.1093/cvr/cvp284 issn: 0008-6363 |
Aparece en las colecciones: | (IQF) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Endocannabinoids.pdf | 795,14 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Page view(s)
57
checked on 22-abr-2024
Download(s)
64
checked on 22-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.